Galectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myeloma.

Mirandola L, Yu Y, Chui K, Jenkins MR, Cobos E, John CM, Chiriva-Internati M

Open source

DOI
10.1371/journal.pone.0021811
Published
2011
Container
PloS one
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0021811,
  title = {Galectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myeloma.},
  author = {Mirandola L and Yu Y and Chui K and Jenkins MR and Cobos E and John CM and Chiriva-Internati M},
  year = {2011},
  journal = {PloS one},
  doi = {10.1371/journal.pone.0021811},
  url = {https://doi.org/10.1371/journal.pone.0021811}
}

RIS

TY  - JOUR
TI  - Galectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myeloma.
AU  - Mirandola L
AU  - Yu Y
AU  - Chui K
AU  - Jenkins MR
AU  - Cobos E
AU  - John CM
AU  - Chiriva-Internati M
PY  - 2011
JO  - PloS one
DO  - 10.1371/journal.pone.0021811
UR  - https://doi.org/10.1371/journal.pone.0021811
ER  - 

APA

L, M., Y, Y., K, C., MR, J., E, C., CM, J., & M, C. (2011). Galectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myeloma.. PloS one. https://doi.org/10.1371/journal.pone.0021811

Source records